Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 3 1 2019
medline: 16 8 2019
entrez: 3 1 2019
Statut: ppublish

Résumé

The incidence of scarlet fever in England and Wales is at its highest in 50 years. We estimated secondary household risk for invasive group A Streptococcus (iGAS) disease within 60 days after onset of scarlet fever. Reports of scarlet fever in England during 2011-2016 were matched by residential address to persons with laboratory-confirmed iGAS infections. We identified 11 iGAS cases in ≈189,684 household contacts and a 60-day incidence rate of 35.3 cases/100,000 person-years, which was 12.2-fold higher than the background rate (2.89). Infants and contacts >75 years of age were at highest risk. Three cases were fatal; sepsis and cellulitis were the most common manifestations. Typing for 6 iGAS cases identified emm 1.0 (n = 4), emm 4.0 (n = 1), and emm 12.0 (n = 1). Although absolute risk in household contacts was low, clinicians assessing household contacts should be aware of the risk to expedite diagnosis and initiate life-saving treatment.

Identifiants

pubmed: 30602121
doi: 10.3201/eid2503.181518
pmc: PMC6390732
doi:

Types de publication

Historical Article Journal Article

Langues

eng

Pagination

529-537

Subventions

Organisme : Medical Research Council
ID : MR/P022669/1
Pays : United Kingdom

Références

Scand J Infect Dis. 1997;29(3):239-44
pubmed: 9255882
Microb Genom. 2016 Jun 24;2(6):e000059
pubmed: 28348855
Lancet Infect Dis. 2018 Feb;18(2):180-187
pubmed: 29191628
Emerg Infect Dis. 2012 Oct;18(10):1658-61
pubmed: 23018120
Euro Surveill. 2014 Mar 27;19(12):20749
pubmed: 24698137
EBioMedicine. 2018 Feb;28:128-135
pubmed: 29342444
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
BMC Genomics. 2017 Mar 10;18(1):224
pubmed: 28283023
Epidemiol Infect. 2015 Jun;143(8):1719-30
pubmed: 25262779
Clin Otolaryngol. 2018 Jun;43(3):912-919
pubmed: 29505705
Clin Infect Dis. 2015 Jan 1;60(1):166-7
pubmed: 25258351
Lancet Infect Dis. 2018 Sep;18(9):942
pubmed: 30152353
MMWR Morb Mortal Wkly Rep. 1997 Oct 10;46(40):944-8
pubmed: 9338455
J Infect. 2012 Jan;64(1):1-18
pubmed: 22120112
Emerg Infect Dis. 2008 Feb;14(2):202-9
pubmed: 18258111
J Hosp Infect. 2014 Jul;87(3):141-4
pubmed: 24928787
Commun Dis Public Health. 2004 Dec;7(4):354-61
pubmed: 15786581
Infect Immun. 2014 Mar;82(3):1141-6
pubmed: 24371220
Epidemiol Infect. 2017 Oct;145(13):2759-2765
pubmed: 28805176
Lancet Infect Dis. 2018 Aug;18(8):823-824
pubmed: 29858151
Clin Microbiol Infect. 2003 Jun;9(6):554-9
pubmed: 12848734
Open Forum Infect Dis. 2018 Jul 20;5(8):ofy177
pubmed: 30109241
Paediatr Child Health. 1999 Jan;4(1):73-82
pubmed: 20212993
J Hosp Infect. 1995 Jun;30(2):162-4
pubmed: 7673692
J Pediatric Infect Dis Soc. 2014 Dec;3(4):336-42
pubmed: 26625454
Arch Dis Child. 1945 Mar;20(101):2-21
pubmed: 21032289
Euro Surveill. 2017 May 11;22(19):
pubmed: 28537550

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH